CELESTIAL

Celestial Biolabs Limited has submitted to the Exchange, the financial results for the period ended September 30, 2018.

Celestial Biolabs Limited has informed the Exchange regarding Board meeting held on November 14, 2018.

Celestial Biolabs Limited has informed the Exchange regarding Clarification on SEBI interim order.

Celestial Biolabs Limited has informed the Exchange regarding voting results of Annual General Meeting held on September 29, 2018

Celestial Biolabs Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 29, 2018

Celestial Biolabs Limited has informed the Exchange that the Register of Members and Share Transfer Books of the Company will remain closed from September 27, 2018 to September 29, 2018 (both day inclusive) for the purpose of Annual General Meeting for the financial year 20187-18 scheduled to be held on September 29,2018.

The Exchange had sought clarification from Celestial Biolabs Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI -2. Financial results not signed by authorized signatory/ies -3. Standalone limited review report not submitted. The response of the Company is enclosed.

Celestial Biolabs Limited has informed the Exchange regarding Outcome of Board Meeting held on September 03, 2018.

Celestial Biolabs Limited has informed the Exchange regarding a press release dated August 23, 2018, titled "Launching of new product".

The Exchange has sought clarification from Celestial Biolabs Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI -2. Financial results not signed by authorized signatory/ies -3. Standalone limited review report not submitted. The response of the Company is awaited.

Celestial Biolabs Limited has submitted to the Exchange, the financial results for the period ended June 30, 2018.

The Exchange had sought clarification from Celestial Biolabs Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results submitted is not as per format prescribed under Schedule III of the Companies Act, 2013. -2. Standalone audited report not submitted. -3. Board meeting notice not submitted. -4. Standalone Reconciliation of Equity not submitted -5. The company has not submitted the Statement of Modified Opinion or in case

The Exchange has sought clarification from Celestial Biolabs Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed under Schedule III of the Companies Act, 2013. -2. Standalone audited report not submitted. -3. Board meeting notice not submitted. -4. Standalone Reconciliation of Equity not submitted- 5. The company has not submitted the Statement of Modified Opinion or in case o

Celestial Biolabs Limited has submitted to the Exchange, the financial results for the period ended 31-Mar-2018.

Celestial Biolabs Limited has informed the Exchange regarding voting results of Extraordinary General Meeting held on May 19, 2018

Celestial Biolabs Limited has informed the Exchange regarding Proceedings of Extraordinary General Meeting held on May 19, 2018

Celestial Biolabs Limited has informed the Exchange regarding Notice of Extraordinary General Meeting to be held on May 19, 2018

Celestial Biolabs Limited has informed the Exchange regarding Board meeting held on April 10, 2018.

Promoter of the Company has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Celestial Biolabs Limited has informed the Exchange regarding Outcome of Board Meeting held on February 14, 2018.

Celestial Biolabs Limited has submitted to the Exchange, the financial results for the period ended 31-Dec-2017.

Celestial Biolabs Limited has submitted to the Exchange, the financial results for the period ended 30-Sep-2017.

The Exchange had sought clarification from Celestial Biolabs Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results not submitted within 30 minutes from end of board meeting. -2. Financial results not submitted as per Schedule III to the Companies Act, 2013 -3. Standalone limited review report not submitted. -4. Reconciliation of profit and loss not submitted. The response of the Company is enclosed.

Celestial Biolabs Limited has informed the Exchange regarding voting results of Annual General Meeting held on September 28, 2017

Celestial Biolabs Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 28, 2017

Celestial Biolabs Limited has informed the Exchange that the Register of Members & Share Transfer Books of the Company will remain closed from September 26, 2017 to September 28, 2017 (both days inclusive) for the purpose of Annual General Meeting for the financial year 2016 - 17 scheduled to be held on September 28, 2017.

The Exchange has sought clarification from Celestial Biolabs Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify. -1. Reconciliation of profit and loss not submitted. -2. Standalone limited review report not submitted. -3. Financial results not submitted as per Schedule III to the Companies Act, 2013 -4. Financial results not submitted within 30 minutes from end of board meeting. The response of the Company is awaited.

Celestial Biolabs Limited has informed the Exchange regarding Outcome of Board Meeting held on September 13, 2017.

Celestial Biolabs Limited has submitted to the Exchange, the financial results for the period ended 30-Jun-2017.

Celestial Biolabs Limited has informed the Exchange regarding Auditors report for the period ended March 31, 2017

Celestial Biolabs Limited has informed the Exchange regarding Declaration for audit reports with unmodified opinion(s)

Celestial Biolabs Limited has informed the Exchange regarding Financial Results Updates

Celestial Biolabs Limited has submitted to the Exchange, the financial results for the period ended 31-Mar-2017.

Dr A N Singh along with PAC has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

A N Singh has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Celestial Biolabs Limited has submitted to the Exchange, the financial results for the period ended 31-Dec-2016.

Celestial Biolabs Limited has submitted to the Exchange a copy of the proceedings of the Annual General Meeting of the Company held on December 30, 2016.

Celestial Biolabs Limited has submitted to the Exchange a copy of the Voting results of the Annual General Meeting of the company held on December 30, 2016 .

Celestial Biolabs Limited has informed the Exchange that the Register of Members and Share Transfer Books of the Company shall remain closed from December 28, 2016 to December 30, 2016 (both days inclusive) for the purpose of Annual General Meeting of the Company scheduled to be held on December 30, 2016.

CELESTIAL:The Exchange had sought clarification from Celestial Biolabs Limited with respect to announcement dated 30-Nov-2016, informing that the Board of Directors in their Board meeting held on November 30, 2016, have transacted the following business : (1) Allotted 21,00,000 equity shares of Rs.10/- each, upon conversion of 21,00,000 convertible warrants, on preferential basis to promoter & non promoter group in accordance with the SEBI Guidelines; (2) To issue 55,94,600 convertible warrants on preferential basis to promoters & non-promoter group, subject to approval from shareholders, stoc

CELESTIAL:The Exchange has sought clarification from Celestial Biolabs Limited with respect to announcement dated 30-Nov-2016, informing that the Board of Directors in their Board meeting held on November 30, 2016, have transacted the following business : (1) Allotted 21,00,000 equity shares of Rs.10/- each, upon conversion of 21,00,000 convertible warrants, on preferential basis to promoter & non promoter group in accordance with the SEBI Guidelines; (2) To issue 55,94,600 convertible warrants on preferential basis to promoters & non-promoter group, subject to approval from shareholders, stoc

Celestial Biolabs Limited has informed the Exchange that the Board of Directors in their Board meeting held on November 30, 2016, have transacted the following business : (1) Allotted 21,00,000 equity shares of Rs.10/- each, upon conversion of 21,00,000 convertible warrants, on preferential basis to promoter & non promoter group in accordance with the SEBI Guidelines; (2) To issue 55,94,600 convertible warrants on preferential basis to promoters & non-promoter group, subject to approval from shareholders, stock exchanges or any statutory body as may be required in this regard.

Celestial Biolabs Limited has submitted to the Exchange, the financial results for the period ended 30-Sep-2016.

Celestial Biolabs Limited has informed the Exchange that in accordance with the provisions of Section 96(1) of the Companies Act, 2013 we have obtained extension of time for convening the Annual General Meeting for the financial year 2015-16 upto 3 months (i.e.,upto December 31, 2016 ) from the Registrar of Companies, Ministry of Corporate Affairs vide their letter dated September 30, 2016.

Celestial Biolabs Limited has submitted to the Exchange the standalone financial results along with the Limited Review Report for the period ended 30-Jun-2016.

Celestial Biolabs Limited has informed the Exchange regarding declaration on audit report with unmodified opinion for the year ended March 31, 2016.

Celestial Biolabs Limited has submitted to the Exchange the standalone financial results along with the Auditors Report for the period ended March 31, 2016.

Dr. A. N. Singh has submitted to the Exchange vide letter dated April 4, 2016 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Celestial Biolabs Limited has informed the Exchange that the Board of Directors in their Board meeting held March 14, 2016 have transacted the following business:(1) Allotted 19,28,000 equity shares of Rs.10/- each, upon conversion of 19,28,000 convertible warrants, on preferential basis to non promoter group in accordance with the SEBI Guidelines.

Celestial Biolabs Limited has submitted to the Exchange the standalone financial results along with the Limited Review Report for the period ended December 31, 2015.